{"product_id":"cardiogen-20mg-vial","title":"Cardiogen 20mg vial","description":"\u003cp data-start=\"0\" data-end=\"95\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0);\"\u003e                                               \u003cspan style=\"text-decoration: underline;\"\u003eNOT \u003c\/span\u003e\u003c\/span\u003e\u003c\/strong\u003e\u003cspan style=\"text-decoration: underline;\"\u003e\u003cstrong\u003e\u003cspan style=\"color: rgb(255, 42, 0); text-decoration: underline;\"\u003eFOR HUMAN CONSUMPTION\u003c\/span\u003e\u003c\/strong\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"97\" data-end=\"364\"\u003e\u003cstrong data-start=\"114\" data-end=\"127\"\u003eCardiogen\u003c\/strong\u003e is most commonly described in the peptide-bioregulator ecosystem as an \u003cstrong data-start=\"199\" data-end=\"226\"\u003eultrashort tetrapeptide\u003c\/strong\u003e with the sequence \u003cstrong data-start=\"245\" data-end=\"276\"\u003eH-Ala-Glu-Asp-Arg-OH (AEDR)\u003c\/strong\u003e, positioned as a \u003cstrong data-start=\"294\" data-end=\"325\"\u003ecardiac tissue bioregulator\u003c\/strong\u003e. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"733\" data-end=\"1060\"\u003e\u003cstrong data-start=\"733\" data-end=\"749\"\u003eCore concept\u003c\/strong\u003e\u003cbr data-start=\"749\" data-end=\"752\"\u003eCardiogen is not framed as a classic receptor agonist drug. It’s proposed to \u003cstrong data-start=\"829\" data-end=\"844\"\u003eenter cells\u003c\/strong\u003e and \u003cstrong data-start=\"849\" data-end=\"905\"\u003einfluence gene expression \/ DNA-associated processes\u003c\/strong\u003e, with particular focus on cardiac repair\/adaptation pathways (often via fibroblast\/cardiomyocyte biology in models). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"1062\" data-end=\"1282\"\u003e\u003cstrong data-start=\"1062\" data-end=\"1083\"\u003eRegulatory status\u003c\/strong\u003e\u003cbr data-start=\"1083\" data-end=\"1086\"\u003eAs commonly sold in “bioregulator \/ research peptide” channels, Cardiogen is \u003cstrong data-start=\"1163\" data-end=\"1199\"\u003enot an FDA\/EMA-approved medicine\u003c\/strong\u003e(no drug-label-grade indications\/safety\/PK). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"1284\" data-end=\"1287\"\u003e\n\u003ch2 data-start=\"1289\" data-end=\"1364\"\u003e1) Additional benefits now under investigation (Cardiogen\/AEDR-centered)\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"1366\" data-end=\"2361\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"1366\" data-end=\"1394\"\u003e\n\u003ctr data-start=\"1366\" data-end=\"1394\"\u003e\n\u003cth data-start=\"1366\" data-end=\"1376\" data-col-size=\"md\"\u003eBENEFIT\u003c\/th\u003e\n\u003cth data-start=\"1376\" data-end=\"1394\" data-col-size=\"xl\"\u003eKEY TAKE-AWAYS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"1405\" data-end=\"2361\"\u003e\n\u003ctr data-start=\"1405\" data-end=\"1629\"\u003e\n\u003ctd data-start=\"1405\" data-end=\"1455\" data-col-size=\"md\"\u003e1) Myocardial repair \/ cellular renewal signals\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1455\" data-end=\"1629\"\u003eDescribed as supporting repair programs in cardiac tissue research; often discussed via \u003cstrong data-start=\"1545\" data-end=\"1577\"\u003efibroblast\/tissue remodeling\u003c\/strong\u003e hypotheses. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1630\" data-end=\"1871\"\u003e\n\u003ctd data-start=\"1630\" data-end=\"1677\" data-col-size=\"md\"\u003e2) Anti-apoptotic \/ stress-adaptation themes\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1677\" data-end=\"1871\"\u003eBioregulator framework sources frequently frame effects around cell survival and stress response (mechanism remains incompletely established in humans). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"1872\" data-end=\"2109\"\u003e\n\u003ctd data-start=\"1872\" data-end=\"1918\" data-col-size=\"md\"\u003e3) DNA processing \/ endonuclease modulation\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"1918\" data-end=\"2109\"\u003eSome descriptions report AEDR can \u003cstrong data-start=\"1954\" data-end=\"1998\"\u003emodulate DNA hydrolysis\/repair processes\u003c\/strong\u003e, possibly via interaction with enzymes rather than direct DNA binding. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"2110\" data-end=\"2361\"\u003e\n\u003ctd data-start=\"2110\" data-end=\"2176\" data-col-size=\"md\"\u003e4) Mitochondrial \/ bioenergetics interest (secondary summaries)\u003c\/td\u003e\n\u003ctd data-col-size=\"xl\" data-start=\"2176\" data-end=\"2361\"\u003eVendor summaries highlight mitochondrial bioenergetics\/calcium homeostasis themes; treat as \u003cstrong data-start=\"2270\" data-end=\"2290\"\u003ehypothesis-level\u003c\/strong\u003e unless linked to primary data. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp data-start=\"2363\" data-end=\"2670\"\u003e\u003cstrong data-start=\"2363\" data-end=\"2389\"\u003eEvidence quality note:\u003c\/strong\u003e The most solidly citable material is \u003cstrong data-start=\"2427\" data-end=\"2457\"\u003emechanistic\/review framing\u003c\/strong\u003e and biochemical interaction claims; robust, widely indexed \u003cstrong data-start=\"2517\" data-end=\"2539\"\u003ehuman outcome RCTs\u003c\/strong\u003e (hard CV endpoints) for Cardiogen itself are not clearly established from the above sources. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"2672\" data-end=\"2675\"\u003e\n\u003ch2 data-start=\"2677\" data-end=\"2712\"\u003e2) Molecular mechanism of action\u003c\/h2\u003e\n\u003ch3 data-start=\"2714\" data-end=\"2758\"\u003e2.1 “Pharmacodynamics” framing (typical)\u003c\/h3\u003e\n\u003cul data-start=\"2759\" data-end=\"3198\"\u003e\n\u003cli data-start=\"2759\" data-end=\"3000\"\u003e\n\u003cp data-start=\"2761\" data-end=\"3000\"\u003e\u003cstrong data-start=\"2761\" data-end=\"2808\"\u003eIntracellular\/nuclear interaction paradigm:\u003c\/strong\u003e ultrashort peptides are proposed to enter nuclei\/nucleoli and interact with DNA\/nucleosome machinery, affecting transcription and DNA repair processes. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"3001\" data-end=\"3198\"\u003e\n\u003cp data-start=\"3003\" data-end=\"3198\"\u003e\u003cstrong data-start=\"3003\" data-end=\"3047\"\u003eAEDR-specific DNA processing modulation:\u003c\/strong\u003e AEDR is described as influencing DNA hydrolysis via endonuclease systems (enzyme-mediated mechanism proposed). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"3200\" data-end=\"3244\"\u003e2.2 Down-stream biology (conceptual map)\u003c\/h3\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"3245\" data-end=\"3770\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"3245\" data-end=\"3310\"\u003e\n\u003ctr data-start=\"3245\" data-end=\"3310\"\u003e\n\u003cth data-start=\"3245\" data-end=\"3254\" data-col-size=\"sm\"\u003eDOMAIN\u003c\/th\u003e\n\u003cth data-start=\"3254\" data-end=\"3299\" data-col-size=\"md\"\u003eFUNCTIONAL OUTCOME (hypothesized\/reported)\u003c\/th\u003e\n\u003cth data-start=\"3299\" data-end=\"3310\" data-col-size=\"md\"\u003eCONTEXT\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"3325\" data-end=\"3770\"\u003e\n\u003ctr data-start=\"3325\" data-end=\"3485\"\u003e\n\u003ctd data-start=\"3325\" data-end=\"3367\" data-col-size=\"sm\"\u003eCardiac fibroblast \/ remodeling biology\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3367\" data-end=\"3409\"\u003erepair\/scar-formation signaling balance\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3409\" data-end=\"3485\"\u003epreclinical\/bioregulator framing \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3486\" data-end=\"3636\"\u003e\n\u003ctd data-start=\"3486\" data-end=\"3521\" data-col-size=\"sm\"\u003eDNA hydrolysis\/repair modulation\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3521\" data-end=\"3563\"\u003ealtered DNA processing in model systems\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3563\" data-end=\"3636\"\u003eenzyme interaction hypothesis \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"3637\" data-end=\"3770\"\u003e\n\u003ctd data-start=\"3637\" data-end=\"3666\" data-col-size=\"sm\"\u003eStress adaptation pathways\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3666\" data-end=\"3693\"\u003esurvival\/repair programs\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"3693\" data-end=\"3770\"\u003ebroad ultrashort peptide paradigm \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"3772\" data-end=\"3775\"\u003e\n\u003ch2 data-start=\"3777\" data-end=\"3804\"\u003e3) Pharmacokinetics (PK)\u003c\/h2\u003e\n\u003cp data-start=\"3805\" data-end=\"4186\"\u003eThere is \u003cstrong data-start=\"3814\" data-end=\"3848\"\u003eno authoritative drug-label PK\u003c\/strong\u003e for Cardiogen in common research\/bioregulator commerce. As an \u003cstrong data-start=\"3911\" data-end=\"3938\"\u003eunmodified tetrapeptide\u003c\/strong\u003e, systemic exposure would generally be expected to be \u003cstrong data-start=\"3992\" data-end=\"4023\"\u003eroute\/formulation dependent\u003c\/strong\u003e and subject to \u003cstrong data-start=\"4039\" data-end=\"4070\"\u003erapid peptidase degradation\u003c\/strong\u003e, making formal PK\/PD bridging critical for any clinical translation claims. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"4188\" data-end=\"4191\"\u003e\n\u003ch2 data-start=\"4193\" data-end=\"4233\"\u003e4) Pre-clinical and clinical evidence\u003c\/h2\u003e\n\u003ch3 data-start=\"4235\" data-end=\"4279\"\u003e4.1 Mechanistic \/ preclinical (stronger)\u003c\/h3\u003e\n\u003cul data-start=\"4280\" data-end=\"4632\"\u003e\n\u003cli data-start=\"4280\" data-end=\"4478\"\u003e\n\u003cp data-start=\"4282\" data-end=\"4478\"\u003eReviews of peptide gene regulation describe ultrashort peptides (including \u003cstrong data-start=\"4357\" data-end=\"4365\"\u003eAEDR\u003c\/strong\u003e) as capable of modulating DNA processing and gene expression pathways. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"4479\" data-end=\"4632\"\u003e\n\u003cp data-start=\"4481\" data-end=\"4632\"\u003eSecondary summaries describe effects on cardiac tissue repair biology (often emphasizing fibroblast targets). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 data-start=\"4634\" data-end=\"4684\"\u003e4.2 Human clinical evidence (weaker \/ unclear)\u003c\/h3\u003e\n\u003cp data-start=\"4685\" data-end=\"4969\"\u003eFrom the retrieved sources here, \u003cstrong data-start=\"4718\" data-end=\"4763\"\u003ehigh-quality, widely indexed human trials\u003c\/strong\u003e showing meaningful clinical outcomes (e.g., EF improvement in HF, post-MI remodeling endpoints, MACE reduction) are \u003cstrong data-start=\"4880\" data-end=\"4907\"\u003enot clearly established\u003c\/strong\u003e for Cardiogen itself. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003chr data-start=\"4971\" data-end=\"4974\"\u003e\n\u003ch2 data-start=\"4976\" data-end=\"5009\"\u003e5) Emerging clinical interests\u003c\/h2\u003e\n\u003cdiv class=\"TyagGW_tableContainer\"\u003e\n\u003cdiv class=\"group TyagGW_tableWrapper flex flex-col-reverse w-fit\" tabindex=\"-1\"\u003e\n\u003ctable data-start=\"5010\" data-end=\"5374\" class=\"w-fit min-w-(--thread-content-width)\"\u003e\n\u003cthead data-start=\"5010\" data-end=\"5040\"\u003e\n\u003ctr data-start=\"5010\" data-end=\"5040\"\u003e\n\u003cth data-start=\"5010\" data-end=\"5018\" data-col-size=\"md\"\u003eFIELD\u003c\/th\u003e\n\u003cth data-start=\"5018\" data-end=\"5030\" data-col-size=\"sm\"\u003eRATIONALE\u003c\/th\u003e\n\u003cth data-start=\"5030\" data-end=\"5040\" data-col-size=\"md\"\u003eSTATUS\u003c\/th\u003e\n\u003c\/tr\u003e\n\u003c\/thead\u003e\n\u003ctbody data-start=\"5055\" data-end=\"5374\"\u003e\n\u003ctr data-start=\"5055\" data-end=\"5215\"\u003e\n\u003ctd data-start=\"5055\" data-end=\"5085\" data-col-size=\"md\"\u003eCardiac repair \/ remodeling\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"5085\" data-end=\"5128\"\u003efibroblast + repair signaling hypothesis\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"5128\" data-end=\"5215\"\u003eearly mechanistic\/preclinical; needs trials \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr data-start=\"5216\" data-end=\"5374\"\u003e\n\u003ctd data-start=\"5216\" data-end=\"5266\" data-col-size=\"md\"\u003e“Cardiometabolic resilience” via stress biology\u003c\/td\u003e\n\u003ctd data-col-size=\"sm\" data-start=\"5266\" data-end=\"5297\"\u003eDNA\/gene-regulation paradigm\u003c\/td\u003e\n\u003ctd data-col-size=\"md\" data-start=\"5297\" data-end=\"5374\"\u003econceptual; translation uncertain \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003chr data-start=\"5376\" data-end=\"5379\"\u003e\n\u003ch2 data-start=\"5381\" data-end=\"5410\"\u003e6) Safety and tolerability\u003c\/h2\u003e\n\u003cp data-start=\"5411\" data-end=\"5668\"\u003e\u003cstrong data-start=\"5411\" data-end=\"5440\"\u003eHigh-certainty statement:\u003c\/strong\u003e Cardiogen in typical “research\/bioregulator” channels does \u003cstrong data-start=\"5500\" data-end=\"5507\"\u003enot\u003c\/strong\u003e come with an FDA\/EMA-style safety label, so contraindications\/interactions\/monitoring are not defined to drug standards. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp data-start=\"5670\" data-end=\"5693\"\u003ePractical risk drivers:\u003c\/p\u003e\n\u003cul data-start=\"5694\" data-end=\"5971\"\u003e\n\u003cli data-start=\"5694\" data-end=\"5853\"\u003e\n\u003cp data-start=\"5696\" data-end=\"5853\"\u003e\u003cstrong data-start=\"5696\" data-end=\"5737\"\u003eIdentity\/purity\/sterility variability\u003c\/strong\u003e across suppliers (especially given sequence inconsistency in the market). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"5854\" data-end=\"5971\"\u003e\n\u003cp data-start=\"5856\" data-end=\"5971\"\u003e\u003cstrong data-start=\"5856\" data-end=\"5887\"\u003eImmunologic\/local reactions\u003c\/strong\u003e are possible with peptides; true rates unknown without regulated pharmacovigilance.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"5973\" data-end=\"5976\"\u003e\n\u003ch2 data-start=\"5978\" data-end=\"6004\"\u003e7) Regulatory landscape\u003c\/h2\u003e\n\u003cul data-start=\"6005\" data-end=\"6174\"\u003e\n\u003cli data-start=\"6005\" data-end=\"6174\"\u003e\n\u003cp data-start=\"6007\" data-end=\"6174\"\u003eGenerally positioned as \u003cstrong data-start=\"6031\" data-end=\"6058\"\u003eresearch \/ bioregulator\u003c\/strong\u003e material rather than an approved therapeutic with standardized indications. \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr data-start=\"6176\" data-end=\"6179\"\u003e\n\u003ch2 data-start=\"6181\" data-end=\"6233\"\u003e8) Future directions (what would validate claims)\u003c\/h2\u003e\n\u003col data-start=\"6234\" data-end=\"6605\"\u003e\n\u003cli data-start=\"6234\" data-end=\"6376\"\u003e\n\u003cp data-start=\"6237\" data-end=\"6376\"\u003e\u003cstrong data-start=\"6237\" data-end=\"6271\"\u003eSequence + GMP standardization\u003c\/strong\u003e (AEDR confirmed by MS\/HPLC; impurities and stability defined). \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6377\" data-end=\"6461\"\u003e\n\u003cp data-start=\"6380\" data-end=\"6461\"\u003e\u003cstrong data-start=\"6380\" data-end=\"6404\"\u003eHuman PK\/PD bridging\u003c\/strong\u003e (exposure, tissue distribution, biomarker engagement).\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6462\" data-end=\"6605\"\u003e\n\u003cp data-start=\"6465\" data-end=\"6605\"\u003e\u003cstrong data-start=\"6465\" data-end=\"6495\"\u003eControlled clinical trials\u003c\/strong\u003e in defined indications (post-MI remodeling, HF biomarkers\/imaging endpoints), plus long-term safety datasets.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003chr data-start=\"6607\" data-end=\"6610\"\u003e\n\u003ch2 data-start=\"6612\" data-end=\"6634\"\u003eSelected references\u003c\/h2\u003e\n\u003cul data-start=\"6635\" data-end=\"7090\"\u003e\n\u003cli data-start=\"6635\" data-end=\"6729\"\u003e\n\u003cp data-start=\"6637\" data-end=\"6729\"\u003eAEDR definition and general Cardiogen description: \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6730\" data-end=\"6850\"\u003e\n\u003cp data-start=\"6732\" data-end=\"6850\"\u003ePeptide gene-expression \/ nuclear interaction framework (systematic review): \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6851\" data-end=\"6970\"\u003e\n\u003cp data-start=\"6853\" data-end=\"6970\"\u003eDNA hydrolysis modulation mention including AEDR among ultrashort peptides: \u003cspan class=\"\" data-state=\"closed\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli data-start=\"6971\" data-end=\"7090\"\u003e\n\u003cp data-start=\"6973\" data-end=\"7090\"\u003eMarketplace inconsistency example (different “Cardiogen” sequence claimed)\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"RCpeptides","offers":[{"title":"Default Title","offer_id":52684843123026,"sku":null,"price":47.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1048\/0956\/2450\/files\/Cardiogen_20mg.png?v=1770834810","url":"https:\/\/sciencepeptideslab.com\/products\/cardiogen-20mg-vial","provider":"Science Peptides Lab","version":"1.0","type":"link"}